Status:
COMPLETED
Carboplatin and Temozolomide (Temodar) for Recurrent and Symptomatic Residual Brain Metastases
Lead Sponsor:
Ohio State University Comprehensive Cancer Center
Conditions:
Brain Tumor
Brain Metastases
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
Purpose: The primary objective of this study is to determine if chemotherapy with carboplatin and temozolomide significantly affects the response rates, or size of disease, in patients with brain meta...
Detailed Description
Rationale: Surgery and radiation are often used as treatments for brain metastases, or tumors in the brain that originate from other parts of the body. It is currently unknown whether patient survival...
Eligibility Criteria
Inclusion
- Pathologically confirmed systemic cancer
Exclusion
- Pregnant
- Known CNS meningeal involvement with cancer
Key Trial Info
Start Date :
October 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2008
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT00362817
Start Date
October 1 2004
End Date
February 1 2008
Last Update
June 1 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ohio State University
Columbus, Ohio, United States, 43210